RecruitingNCT06669104

Thoracic Surgery by the Medtronic Hugo™ Robotic System

Thoracic Surgery by the Medtronic Hugo™ Robotic System: A Prospective Single Centre Study


Sponsor

Chinese University of Hong Kong

Enrollment

50 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The introduction of robot-assisted surgery is one of the biggest breakthroughs in surgery, and represents the most significant advancement in minimally invasive surgery of recent decades. One of the first surgical uses of the robot was in orthopaedics, neurosurgery and cardiac surgery. However, it's use has now been well recognized in thoracic surgical procedures ranging from mediastinal tumour resection to complex major lung resections. Robotic surgery by the da Vinci Surgical System (Intuitive Surgical, Inc) has been one of the most commonly used robotic systems in surgery. The robotic system overcomes the limitations of the standard thoracoscopic approach and allows for precise dissection in a confined space. These advantages include stable operator-controlled camera, high- definition 3D magnified view of 10 to 12 times, articulating instruments with seven degrees of freedom, motion scaling, and tremor filtration. Recently the Medtronic Hugo™ surgical robotic system has passed the CE mark. This robotic platform, made up of modular surgical arms on wheeled carts, has started its operation in human in Latin America, Europe and the Asia-Pacific region. The Hugo™ system is designed to provide a lower barrier to entry for hospitals looking to expand their reach in robotic surgery. Compared to the platform by Intuitive Surgical, Hugo™can be customized with up to four independent arms, and rolled to different locations in a hospital when needed. The investigator's centre is the first robotic surgical centre in Hong Kong since 2005. Over the years, the investigator have established the centre to be one of the leading centre in Hong Kong and the region, with involvement in various new development in thoracic robotic procedures, publications and books, and more recently in robotic endo-lumenal procedures. In this study, the investigator evaluate the early surgical outcome and objective functional outcome of patients undergoing robotic thoracic surgery by the Medtronic Hugo™ surgical robotic system.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates the safety and outcomes of thoracic (chest) surgery performed using the Medtronic Hugo™ robotic surgical system. It is an observational study tracking real-world results from patients who undergo chest surgery with this robot. **You may be eligible if...** - You are between 18 and 80 years old - Your BMI is under 35 - You are a candidate for minimally invasive chest surgery - You are willing and able to give informed consent **You may NOT be eligible if...** - You cannot safely receive general anesthesia - You have a serious illness that greatly shortens life expectancy - You have an active untreated infection - You have an uncorrectable bleeding disorder - You need emergency surgery - You are pregnant or have a cognitive disability Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMedtronic Hugo™ surgical robotic system

undergoing robotic thoracic surgery by the Medtronic Hugo™ surgical robotic system


Locations(1)

Prince of Wales Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06669104


Related Trials